© Copyright by HealthHelpZone.com. All rights reserved.
Boston (June 27, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it received notice from the NASDAQ Stock Market (“NASDAQ”) that it was granted a hearing before a Nasdaq Hearings Panel (the “Panel”). This upcoming hearing, occurring in approximately 5 weeks, is scheduled for the... ❯❯❯
Philadelphia Magazine names Cross Medical Group’s founder as one of the city’s top doctors for 2024PHILADELPHIA, June 26, 2024 (GLOBE NEWSWIRE) -- Each year, Philadelphia Magazine publishes an issue celebrating the top doctors in the city, and Cross Medical Group founder Dr. Kevin J. Cross, a world-renowned plastic surgeon based in Villanova and Philadelphia, is among the medical professionals featured in the 2024 edition. ... ❯❯❯
All Seniors Care Residents to Adorn Buildings in Red and White for Canada DayTORONTO, June 26, 2024 (GLOBE NEWSWIRE) -- As Canada’s birthday approaches, seniors at All Seniors Care residences across the country are gearing up to celebrate in style. This year, the festivities will kick off on Thursday, June 27th, with "Hang Your Flag Day," where residents will hang Canadian flags from their balconies. The Canada Day festivities will... ❯❯❯
MARKHAM, Ontario, June 26, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the renewal of Extendicare’s normal course issuer bid (“NCIB”). Under the terms of the NCIB, the Company may purchase for cancellation up to 7,159,997 of its common shares (the “Common Shares”), representing 10% of its public float of issued and... ❯❯❯
KNOXVILLE, Tenn., June 25, 2024 (GLOBE NEWSWIRE) -- TeamHealth, the leading physician practice in the United States, today announced that it is recognized as one of America’s Greatest Workplaces for 2024 by Newsweek and Plant-A Insights Group. This recognition highlights the incredible dedication by TeamHealth’s clinicians and associates to create an environment centered on well-being, trust and collaboration to deliver high-quality... ❯❯❯
TOKYO, June 25, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”), a holistic healthcare company based in Japan, announced it filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission ("SEC"), including consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles... ❯❯❯
Multiple patients have now exceeded 30 weeks on treatment Boston (June 25, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that multiple patients in its Phase 2 clinical trial of stenoparib for advanced recurrent ovarian cancer have been on treatment for more than 30 weeks. The... ❯❯❯
BEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on June 20, 2024, the Company entered into a Securities Purchase Agreement (the “SPA”) with certain non-U.S. investors (each individually, a “Purchaser,” and collectively, the “Purchasers”). Pursuant to the SPA, the Company will... ❯❯❯
LEWISVILLE, Texas, June 24, 2024 (GLOBE NEWSWIRE) -- BayMark Health Services announces that, after a long and successful career in the behavioral health and addiction field, David K. White, PhD, is stepping down from his role as CEO. During his 16-year tenure at BayMark, Dr. White positioned the organization as a champion for substance use disorder treatment to all the individuals and communities that BayMark serves. His leadership... ❯❯❯
Treatment Costs Reduced by around 80% and Accelerated Access to Treatment RIYADH, Saudi Arabia, June 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has successfully produced CAR T-cells internally for cancer treatment. This breakthrough has reduced the cost of treatment from 1.3 million SAR to approximately 250,000 SAR per treatment, making it available to patients within 14... ❯❯❯